You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Merck
Baxter
Johnson and Johnson
Dow

Last Updated: December 4, 2023

Drug Price Trends for FUROSEMIDE


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for FUROSEMIDE

Average Pharmacy Cost for FUROSEMIDE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
FUROSEMIDE 80 MG TABLET 69315-0118-05 0.05639 EACH 2023-11-22
FUROSEMIDE 10 MG/ML SOLUTION 00054-3294-46 0.08074 ML 2023-11-22
FUROSEMIDE 10 MG/ML SOLUTION 00054-3294-50 0.08074 ML 2023-11-22
FUROSEMIDE 20 MG TABLET 00054-4297-25 0.02684 EACH 2023-11-22
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for FUROSEMIDE

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
FUROSCIX 80MG/10ML, KIT SC Pharmaceuticals Inc. 71767-0100-01 1 603.09 603.09000 EACH 2023-11-15 - 2028-11-14 FSS
FUROSEMIDE 80MG TAB AvKare, LLC 43547-0403-50 500 25.97 0.05194 EACH 2023-06-15 - 2028-06-14 FSS
FUROSEMIDE 40MG/5ML SOLN,5ML Golden State Medical Supply, Inc. 68094-0867-62 30X5ML 61.25 2023-06-16 - 2028-06-14 FSS
FUROSEMIDE 40MG/5ML SOLN,5ML Golden State Medical Supply, Inc. 68094-0867-62 30x5ML 61.25 2023-08-25 - 2028-06-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKesson
Moodys
Medtronic
AstraZeneca
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.